Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases

Journal:
Journal of Infectious Diseases
Published:
DOI:
10.1093/infdis/jiaf395
Affiliations:
3
Authors:
8
Go to article
Institutions Authors Share
GlaxoSmithKline USA, United States of America (USA)
4.000000
 0.50
GlaxoSmithKline Belgium, Belgium
3.000000
 0.38
GlaxoSmithKline Pharmaceuticals Limited, India
1.000000
 0.13
Interested in Clinical Sciences?